4 Steps To Toned Thighs — From Beyonce's Trainer
We found the workout that gave Beyonce her flawless body.
Posts From King World News
Why Sugar Is Poison for Depression
I have a theory: Many people who suffer from chronic severe depression and anxiety are allergic to sugar and foods like white flour that the human body processes like sugar.
Amazon rumored to be purchasing Richemont-owned Net-A-Porter
Promotional image for Net-A-Porter premier delivery service Online marketplace Amazon may be in talks to purchase British ecommerce site Net-A-Porter, if reports that have been rumored are true. The etail giant has been unsuccessful in entering the luxury industry in spite of attempts in recent years, and this potential acquisition could be significant for the future of both companies. The impact that this purchase could have on Net-A-Porter is unclear,
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Revett Mining Company, Inc. of Commencement of an Investigation Concerning the Fairness of the Sale of the Company to Hecla Mining Company
[Business Wire] – The following statement is being issued by Levi & Korsinsky, LLP:
Revett Minerals Inc.: HECLA TO ACQUIRE REVETT IN $20 MILLION STOCK DEAL
Hecla to Acquire Revett in $20 Million Stock Deal
[Business Wire] – Hecla Mining Company and Revett Mining Company, Inc. today announced that they have entered into a merger agreement pursuant to which Hecla will acquire Revett.
Friday, March 27: Today in Gold and Silver
NEW YORK (TheStreet) — Gold opened flat when trading began in New York on Wednesday evening. Then starting just before 9 a.m. Hong Kong time, a rally began that grew stronger as the Far East trading session unfolded. It was up a decent amount by the London open—and then went vertical at 8:00 a.m. GMT, but ran into the usual not-for-profit sellers less than fifteen minutes later—and by 9 a.m.
Mine dispute involving Montana ex-governor headed for trial
U.S. Ebola patient's condition improved to serious: NIH
WASHINGTON (Reuters) – A U.S. patient being treated for the Ebola virus at a National Institutes of Health facility in Maryland has improved to serious condition from critical, the NIH said on Thursday. (Reporting by Emily Stephenson; Editing by Lisa Lambert)
Morphosys, Celgene end cooperation on MOR202 drug candidate
FRANKFURT (Reuters) – Morphosys and Celgene have agreed to end their cooperation on MOR202, but clinical trials of the drug candidate will continue, Morphosys said on Thursday. Morphosys said it aimed to release first clinical data from the ongoing phase 1/2a trial at a medical conference in 2015. It also raised its 2015 profit guidance, saying it expected to post 2015 earnings before interest and tax (EBIT) of between 9